INVO Bioscience Enters into Agreement with Ovoclinic in Spain to Expand INVOcell Commercialisation
Agreement follows initial utilisation of INVOcell by Ovoclinic phyisicians in early 2021, resulting in successful patient experiences and outcomes Ovoclinic will expand use of INVOcell in all four of their clinics...